The White House announced its monkeypox vaccine strategy in response to a rise in reported cases in the United States. In the coming weeks, the administration will allocate 296,000 doses of the two-dose Jynneos vaccine, the only FDA-approved vaccine specifically for monkeypox. Of those, 56,000 doses that are already in the Strategic National Stockpile will be allocated immediately, focused on communities most at risk. Roughly 1.6 million additional doses will become available over the coming months. The White House also noted that monkeypox is much less transmissible than COVID-19 and the current monkeypox outbreak has not caused any deaths in the U.S.
Biden Administration FDA Vaccines Monkeypox
This topic is part of 2 timelines. Explore the complete timeline to see this item in a broader context.